Purpose To investigate whether the cost-effective, pretreatment tumor markers
carcinoembryonic antigen (CEA) and carbohydrate antigen-125 (CA-125) can be used to …

Loss of estrogen receptor/progesterone receptor (ER/PR) in endometrial cancer (EC) is
associated with tumor progression and poor outcomes. Elevated pretreatment cancer …

Background In endometrial carcinoma (EC), preoperative classification is based on
histopathological criteria, with only moderate diagnostic performance for the risk of lymph …

We aimed to evaluate the value of immunohistochemical markers and serum CA125 in
predicting the risk of lymph node metastasis (LNM) in women with endometrial cancer and to …

Purpose The aim of this study was to develop a preoperative risk prediction model for lymph
node metastasis in patients with endometrial cancer and to identify a low-risk group before …

Objectives: To investigate the diagnostic performance of the serum cancer antigen 125
(CA125), human epididymis protein 4 (HE4), a combination of CA125 and HE4, and a risk of …

Aim To establish a risk‐scoring system for lymph node metastasis (LNM) of early‐stage
endometrial carcinoma (EC), and to stratify the preoperative risk of LNM. Methods We …

OBJECTIVES: To evaluate the correlation of pre-operative systemic inflammatory response
(SIR) markers with lymph node (LN) metastasis compared with serum CA-125 in …

Due to advances of radiological imaging and tumor biomarkers, the extent of information
provided by preoperative assessment is rapidly growing. The K orean Gynecologic …

Introduction Endometrial cancer (EC) has high mortality at advanced stages. Poor
prognostic factors include grade 3 tumors, deep myometrial invasion, lymph node …